TITLE

BRAIN CANCER DRUG GETS ORPHAN DRUG DESIGNATION FROM EMEA

PUB. DATE
June 2002
SOURCE
Worldwide Biotech;Jun2002, Vol. 14 Issue 6, p1
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports that DTI-015, an anti-cancer agent designed for direct injection to malignant brain tumor from Direct Therapeutics Incorporated have been granted Orphan Drug designation by the European Agency for the Evaluation of Medicinal Products.
ACCESSION #
6772510

 

Related Articles

  • Protective Effects of Rasayanas on Cyclophosphamide- and Radiation-Induced Damage. Vayalil, Praveen K.; Kuttan, Girija; Kuttan, Ramadasan // Journal of Alternative & Complementary Medicine;Dec2002, Vol. 8 Issue 6, p787 

    Rasayanas are a group of herbal drug preparations widely used in Ayurveda to improve the general health of the body. In mice, Rasayanas are potent myeloprotective agents against chemotherapeutic agents and radiation. Rasayanas are also effective myeloprotectors in patients with cancer undergoing...

  • Clinical endpoints in trials of drugs for cancer: time for a rethink? Koopmans, P. P. // BMJ: British Medical Journal (International Edition);6/8/2002, Vol. 324 Issue 7350, p1389 

    Presents clinical endpoints in trials of drugs for cancer. Need for improvements in the market of drugs for lethal diseases, such as cancer; Suggestion that more attention should be given to clinical symptoms and quality of life and less to survival; How surrogate endpoints and biomarkers...

  • Botanists Search For Anti-Cancer Plants.  // National Wildlife (World Edition);Aug/Sep87, Vol. 25 Issue 5, p28 

    Reports on the research for plants with cancer-fighting potential by botanists under contract with the National Cancer Institute in the U.S. Priority to plants with a history of medical use among native people; Emphasis on the discovery of the periwinkle which has yielded drugs against...

  • Recombinant mistletoe lectin induces p53-independent apoptosis in tumour cells and cooperates with ionising radiation. Hostanska, K; Vuong, V; Rocha, S; Soengas, M S; Glanzmann, C; Saller, R; Bodis, S; Pruschy, M // British Journal of Cancer;6/2/2003, Vol. 88 Issue 11, p1785 

    Mistletoe extracts are used as alternative cancer treatment in addition to standard chemotherapy and radiation treatment and have an immunostimulatory and pain-relieving effect. A direct antitumour effect of mistletoe extracts against tumour cells of lymphoid origin has been linked to the...

  • Dosimetric Verification of IMRT Treatment Plans Using an Electronic Portal Imaging Device. Kruszyna, Marta // AIP Conference Proceedings;1/5/2010, Vol. 1204 Issue 1, p198 

    This paper presents the procedures and results of dosimetric verification using an Electronic Portal Imaging Device as a tool for pre-treatment dosimetry in IMRT technique at the Greater Poland Cancer Centre in Poznan, Poland. The ewaluation of dosimetric verification for various organ, during a...

  • Médecine personnalisée et cancer : gardons les pieds sur terre tout en observant les étoiles. Grudé, F.; Milano, G. // Oncologie;Feb2014, Vol. 16 Issue 2/3, p89 

    No abstract available.

  • Matrix Metalloproteinase Inhibitors as Anticancer Therapeutics. Mannello, F.; Tonti, G.; Papa, S. // Current Cancer Drug Targets;Jun2005, Vol. 5 Issue 4, p285 

    Matrix metalloproteinases (MMPs), also designated as matrixins, play a central role in many biological processes and are involved both in physiologic cellular processes and in pathologic situations such as tumor growth, invasion and metastasis. For more than 30 years MMPs have been considered as...

  • The Use of Complementary and Alternative Medicine Among Chinese Women with Breast Cancer. Zhi Chen; Kai Gu; Ying Zheng; Wei Zheng; Wei Lu; Xiao Ou Shu // Journal of Alternative & Complementary Medicine;Oct2008, Vol. 14 Issue 8, p1049 

    Objectives: Using data from the Shanghai Breast Cancer Survival Study (SBCSS), we estimated the prevalence and perceived benefits of complementary and alternative medicine (CAM) and Chinese herbal medicine (CHM), and relevant demographic and clinical factors. Design: This was a cross-sectional...

  • Treating of Bladder Carcinoma with Oriental Medicine--Part Two. Burton, William // American Acupuncturist;Spring2004, Vol. 30, p20 

    Part II. Presents a case study of a cancer patient who has elected to use chemotherapeutic agents in combination with Oriental medicine botanical therapies. Refusal of surgery because of its negative impact on quality of life; Application of the Eight Principle theory to the patient's...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics